[
  {
    "ts": "2026-02-19T10:15:00+00:00",
    "headline": "Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons",
    "summary": "RAHWAY, N.J., February 19, 2026--Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 at Increased Risk for Severe RSV Over Two RSV Seasons",
    "url": "https://finance.yahoo.com/news/merck-announces-positive-data-enflonsia-101500519.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "031fb74b-6bcf-359f-945a-191346b87cd4",
      "content": {
        "id": "031fb74b-6bcf-359f-945a-191346b87cd4",
        "contentType": "STORY",
        "title": "Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 Years of Age at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease Over Two RSV Seasons",
        "description": "",
        "summary": "RAHWAY, N.J., February 19, 2026--Merck Announces Positive New Data for ENFLONSIA™ (clesrovimab) for Infants and Children Under 2 at Increased Risk for Severe RSV Over Two RSV Seasons",
        "pubDate": "2026-02-19T10:15:00Z",
        "displayTime": "2026-02-19T10:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/5af9b5c82857067df5ef8df81f116630",
          "originalWidth": 480,
          "originalHeight": 217,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N3PImRKKxuTdKapmvOn_VQ--~B/aD0yMTc7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5af9b5c82857067df5ef8df81f116630.cf.webp",
              "width": 480,
              "height": 217,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4r_fbnO.NLd1v.w1vAv1OQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5af9b5c82857067df5ef8df81f116630.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-announces-positive-data-enflonsia-101500519.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-announces-positive-data-enflonsia-101500519.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T10:46:44+00:00",
    "headline": "MSD and Mayo Clinic team up to advance AI in drug development",
    "summary": "MSD will integrate clinical insights and genomic datasets from Mayo Clinic Platform, aggregating data in a secure environment.",
    "url": "https://www.pharmaceutical-technology.com/news/msd-mayo-ai-drug-development/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "e58eaa9f-6356-3bf6-874d-7bf7b02692bf",
      "content": {
        "id": "e58eaa9f-6356-3bf6-874d-7bf7b02692bf",
        "contentType": "STORY",
        "title": "MSD and Mayo Clinic team up to advance AI in drug development",
        "description": "",
        "summary": "MSD will integrate clinical insights and genomic datasets from Mayo Clinic Platform, aggregating data in a secure environment.",
        "pubDate": "2026-02-19T10:46:44Z",
        "displayTime": "2026-02-19T10:46:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/f1974015474f509a725dee931cd1e78d",
          "originalWidth": 1440,
          "originalHeight": 810,
          "caption": "The partnership gives MSD access to datasets",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3sH96HUKCBY4m01B9kd7VQ--~B/aD04MTA7dz0xNDQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/f1974015474f509a725dee931cd1e78d.cf.webp",
              "width": 1440,
              "height": 810,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rUhZnKLZZHvheq6f09BPHA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/f1974015474f509a725dee931cd1e78d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/msd-mayo-ai-drug-development/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/msd-mayo-clinic-team-advance-104644413.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T12:24:00+00:00",
    "headline": "3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players",
    "summary": "The global 3D protein structure analysis market is rapidly expanding due to growing demand in drug development, personalized medicine, and biotech research. Key opportunities include advancements in AI and cloud computing, increased R&D investment, and strategic growth in Asia-Pacific. 3D Protein Structure Analysis Market 3D Protein Structure Analysis Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"3D Protein Structure Analysis: Global Markets\" has been added to ResearchAndMarkets.com's of",
    "url": "https://finance.yahoo.com/news/3d-protein-structure-analysis-market-122400549.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "843732f4-6d51-3a3d-b37d-3bed637bdea2",
      "content": {
        "id": "843732f4-6d51-3a3d-b37d-3bed637bdea2",
        "contentType": "STORY",
        "title": "3D Protein Structure Analysis Market Report 2026 Featuring Profiles of Merck, Bruker Corp., Thermo Fisher Scientific, JEOL, Spectris and Other Leading Players",
        "description": "",
        "summary": "The global 3D protein structure analysis market is rapidly expanding due to growing demand in drug development, personalized medicine, and biotech research. Key opportunities include advancements in AI and cloud computing, increased R&D investment, and strategic growth in Asia-Pacific. 3D Protein Structure Analysis Market 3D Protein Structure Analysis Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"3D Protein Structure Analysis: Global Markets\" has been added to ResearchAndMarkets.com's of",
        "pubDate": "2026-02-19T12:24:00Z",
        "displayTime": "2026-02-19T12:24:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/cd12717e43c6e05ac1dbca8ae1f8f32e",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "3D Protein Structure Analysis Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k.m26AQo_wfGwasslv3fYA--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cd12717e43c6e05ac1dbca8ae1f8f32e.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/E9rR5Wd.22EIF_F80XWBLA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/cd12717e43c6e05ac1dbca8ae1f8f32e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/3d-protein-structure-analysis-market-122400549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3d-protein-structure-analysis-market-122400549.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "BRKR"
            },
            {
              "symbol": "TMO"
            },
            {
              "symbol": "SEPJF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T12:22:00+00:00",
    "headline": "$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More",
    "summary": "Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene Therapy Tools and Reagents Market Cell & Gene Therapy Tools and Reagents Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"Cell and Gene Therapy Tools and Reagents: Global Markets\" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene therapy tools and reagents is",
    "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "9d5176e9-d523-318b-be9c-33f1e5f870c4",
      "content": {
        "id": "9d5176e9-d523-318b-be9c-33f1e5f870c4",
        "contentType": "STORY",
        "title": "$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More",
        "description": "",
        "summary": "Emerging technologies, increasing focus on R&D, and a growing demand in treating previously incurable diseases present significant opportunities across diverse applications and regions Cell & Gene Therapy Tools and Reagents Market Cell & Gene Therapy Tools and Reagents Market Dublin, Feb. 19, 2026 (GLOBE NEWSWIRE) -- The \"Cell and Gene Therapy Tools and Reagents: Global Markets\" has been added to ResearchAndMarkets.com's offering.The global market for cell and gene therapy tools and reagents is",
        "pubDate": "2026-02-19T12:22:00Z",
        "displayTime": "2026-02-19T12:22:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "Cell & Gene Therapy Tools and Reagents Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lCwnbT5CutkKQOCxNZL60Q--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yn.LMVeb3C8KN5SOS7qSFA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/bcb891829ad73080a96d7205b49b32ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/19-8-billion-cell-gene-122200041.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "TMO"
            },
            {
              "symbol": "DHR"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "SARTF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T14:52:43+00:00",
    "headline": "Where is Merck & Co., Inc. (MRK) Headed According to the Street?",
    "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the best immunotherapy stocks to buy according to hedge funds. On February 13, Merck & Co., Inc. (NYSE:MRK) was upgraded to Buy from Hold by Deutsche Bank, with the firm raising the price target to $150 from $115 and telling investors that it believes the market is […]",
    "url": "https://finance.yahoo.com/news/where-merck-co-inc-mrk-145243554.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "dd0eb5ab-9402-36a3-8aa2-f1803949c683",
      "content": {
        "id": "dd0eb5ab-9402-36a3-8aa2-f1803949c683",
        "contentType": "STORY",
        "title": "Where is Merck & Co., Inc. (MRK) Headed According to the Street?",
        "description": "",
        "summary": "Merck & Co., Inc. (NYSE:MRK) is one of the best immunotherapy stocks to buy according to hedge funds. On February 13, Merck & Co., Inc. (NYSE:MRK) was upgraded to Buy from Hold by Deutsche Bank, with the firm raising the price target to $150 from $115 and telling investors that it believes the market is […]",
        "pubDate": "2026-02-19T14:52:43Z",
        "displayTime": "2026-02-19T14:52:43Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Why Merck & Co (MRK) Continues to Rank Among the Most Profitable Dividend Stocks",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IzRhrl6IP..dz_8NtaA67g--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C.KM1e7Q4T5mCkqt60S1Yg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/where-merck-co-inc-mrk-145243554.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/where-merck-co-inc-mrk-145243554.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T13:21:00+00:00",
    "headline": "AtaiBeckley names Michael Faerm as finance chief",
    "summary": "AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC) announced that it has appointed Michael Faerm as chief financial officer, effective March 9, 2026, as the clinical-stage biotechnology company continues to advance its mental health treatment pipeline. According to the company, Faerm brings more than 25...",
    "url": "https://www.proactiveinvestors.com/companies/news/1087626/ataibeckley-names-michael-faerm-as-finance-chief-1087626.html",
    "source": "Proactive",
    "provider": "yfinance",
    "raw": {
      "id": "a9216f54-adc1-3f8d-bcfa-3b88463f69cb",
      "content": {
        "id": "a9216f54-adc1-3f8d-bcfa-3b88463f69cb",
        "contentType": "STORY",
        "title": "AtaiBeckley names Michael Faerm as finance chief",
        "description": "",
        "summary": "AtaiBeckley NV (NASDAQ:ATAI, XETRA:9VC) announced that it has appointed Michael Faerm as chief financial officer, effective March 9, 2026, as the clinical-stage biotechnology company continues to advance its mental health treatment pipeline. According to the company, Faerm brings more than 25...",
        "pubDate": "2026-02-19T13:21:00Z",
        "displayTime": "2026-02-19T13:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/proactive_us_504/b0ddfb07fcad8cebccaf61345fd8d80f",
          "originalWidth": 1079,
          "originalHeight": 720,
          "caption": "AtaiBeckley names Michael Faerm as finance chief",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U44frEVc3FCr.t_jha6GsQ--~B/aD03MjA7dz0xMDc5O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/proactive_us_504/b0ddfb07fcad8cebccaf61345fd8d80f.cf.webp",
              "width": 1079,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kbWWPr49TzCi7fD317UdIA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/proactive_us_504/b0ddfb07fcad8cebccaf61345fd8d80f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Proactive",
          "url": "https://www.proactiveinvestors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.proactiveinvestors.com/companies/news/1087626/ataibeckley-names-michael-faerm-as-finance-chief-1087626.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/ataibeckley-names-michael-faerm-finance-132100371.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ATAI"
            },
            {
              "symbol": "VIRX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "INVA"
            },
            {
              "symbol": "ARTV"
            },
            {
              "symbol": "REGN"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]